The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics' oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness.
source https://www.cnn.com/2021/11/04/health/uk-authorizes-merck-antiviral-molnupiravir-covid/index.html